{"title":"探索绿色微藻杜纳利藻中的蛋白质 N-糖基化","authors":"Jaber Dehghani, Juliette Balieu, Olivier Perruchon, Elodie Mathieu-Rivet, Narimane Mati-Baouche, Patrice Lerouge , Muriel Bardor","doi":"10.1016/j.algal.2024.103711","DOIUrl":null,"url":null,"abstract":"<div><p><em>N</em>-glycosylation is a major post-translational modification of proteins that has a crucial influence on cell targeting, activity, and half-life. This process starts in the endoplasmic reticulum where an oligosaccharide precursor is added to the newly synthesized protein and continues in the Golgi apparatus where the <em>N</em>-linked carbohydrate sequences are processed. Importantly, the most approved recombinant pharmaceutical proteins (so-called biologics) are glycoproteins mainly currently produced in mammalian cells which is a lengthy, costly, and complex process. Today, several microalgae such as the diatom <em>Phaeodactylum tricornutum</em>, and the green microalgae <em>Chlamydomonas reinhardtii</em>, <em>Chlorella vulgaris</em>, and <em>Dunaliella salina</em> are considered as efficient and eco-friendly alternative platforms for the production of biologics. However, unlike for <em>C. reinhardtii</em>, <em>C. vulgaris</em>, and <em>P. tricornutum</em>, there is to date no data reported regarding the protein <em>N</em>-glycosylation pathway in <em>D. salina</em>. Here, we first investigated the protein <em>N</em>-glycosylation in this green microalga by MALDI-TOF mass spectrometry. These analyses showed that proteins from <em>D. salina</em> are <em>N</em>-glycosylated with Man<sub>5</sub>GlcNAc<sub>2</sub> oligomannoside. Using genome mining approaches, we then identified genes encoding proteins involved in the <em>N</em>-glycosylation pathways in <em>D. salina</em>. Genetic similarities and phylogenetic relationships of the putative sequences with homologues from <em>C. reinhardtii</em>, <em>P. tricornutum</em>, and humans were investigated. These data revealed that in <em>D. salina</em> the biosynthesis of nucleotide sugars and <em>N</em>-glycan biosynthesis share mainly similarities with the GnT I-independent pathway of <em>C. reinhardtii</em> that gives rise to the synthesis of a non-canonical oligomannoside Man<sub>5</sub>GlcNAc<sub>2</sub>. Although an α(1,3)-fucosyltransferase is identified in the <em>D. salina</em> genome, impairment of the cytosolic GDP-Fuc biosynthesis prevents the Golgi fucosylation of <em>N</em>-glycans. Taken together, these data demonstrated that proteins from <em>D. salina</em> are homogeneously <em>N</em>-glycosylated with a non-canonical Man<sub>5</sub>GlcNAc<sub>2</sub>.</p></div>","PeriodicalId":7855,"journal":{"name":"Algal Research-Biomass Biofuels and Bioproducts","volume":"83 ","pages":"Article 103711"},"PeriodicalIF":4.6000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211926424003230/pdfft?md5=bac82a2207e8769737316fcaf130ed9b&pid=1-s2.0-S2211926424003230-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Exploring protein N-glycosylation in the green microalga Dunaliella salina\",\"authors\":\"Jaber Dehghani, Juliette Balieu, Olivier Perruchon, Elodie Mathieu-Rivet, Narimane Mati-Baouche, Patrice Lerouge , Muriel Bardor\",\"doi\":\"10.1016/j.algal.2024.103711\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><em>N</em>-glycosylation is a major post-translational modification of proteins that has a crucial influence on cell targeting, activity, and half-life. This process starts in the endoplasmic reticulum where an oligosaccharide precursor is added to the newly synthesized protein and continues in the Golgi apparatus where the <em>N</em>-linked carbohydrate sequences are processed. Importantly, the most approved recombinant pharmaceutical proteins (so-called biologics) are glycoproteins mainly currently produced in mammalian cells which is a lengthy, costly, and complex process. Today, several microalgae such as the diatom <em>Phaeodactylum tricornutum</em>, and the green microalgae <em>Chlamydomonas reinhardtii</em>, <em>Chlorella vulgaris</em>, and <em>Dunaliella salina</em> are considered as efficient and eco-friendly alternative platforms for the production of biologics. However, unlike for <em>C. reinhardtii</em>, <em>C. vulgaris</em>, and <em>P. tricornutum</em>, there is to date no data reported regarding the protein <em>N</em>-glycosylation pathway in <em>D. salina</em>. Here, we first investigated the protein <em>N</em>-glycosylation in this green microalga by MALDI-TOF mass spectrometry. These analyses showed that proteins from <em>D. salina</em> are <em>N</em>-glycosylated with Man<sub>5</sub>GlcNAc<sub>2</sub> oligomannoside. Using genome mining approaches, we then identified genes encoding proteins involved in the <em>N</em>-glycosylation pathways in <em>D. salina</em>. Genetic similarities and phylogenetic relationships of the putative sequences with homologues from <em>C. reinhardtii</em>, <em>P. tricornutum</em>, and humans were investigated. These data revealed that in <em>D. salina</em> the biosynthesis of nucleotide sugars and <em>N</em>-glycan biosynthesis share mainly similarities with the GnT I-independent pathway of <em>C. reinhardtii</em> that gives rise to the synthesis of a non-canonical oligomannoside Man<sub>5</sub>GlcNAc<sub>2</sub>. Although an α(1,3)-fucosyltransferase is identified in the <em>D. salina</em> genome, impairment of the cytosolic GDP-Fuc biosynthesis prevents the Golgi fucosylation of <em>N</em>-glycans. Taken together, these data demonstrated that proteins from <em>D. salina</em> are homogeneously <em>N</em>-glycosylated with a non-canonical Man<sub>5</sub>GlcNAc<sub>2</sub>.</p></div>\",\"PeriodicalId\":7855,\"journal\":{\"name\":\"Algal Research-Biomass Biofuels and Bioproducts\",\"volume\":\"83 \",\"pages\":\"Article 103711\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2211926424003230/pdfft?md5=bac82a2207e8769737316fcaf130ed9b&pid=1-s2.0-S2211926424003230-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Algal Research-Biomass Biofuels and Bioproducts\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211926424003230\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Algal Research-Biomass Biofuels and Bioproducts","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211926424003230","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
N- 糖基化是蛋白质的一种主要翻译后修饰,对细胞靶向、活性和半衰期有重要影响。这一过程始于内质网,在那里寡糖前体被添加到新合成的蛋白质中,然后继续在高尔基体中对 N-连接的碳水化合物序列进行加工。重要的是,目前大多数获批的重组药物蛋白(所谓的生物制剂)都是糖蛋白,主要由哺乳动物细胞生产,这是一个漫长、昂贵和复杂的过程。如今,一些微藻类,如硅藻三尖杉、绿色微藻类莱茵衣藻、绿藻和盐生杜莎藻,被认为是生产生物制剂的高效、环保的替代平台。然而,与莱茵球藻、绿球藻和三色堇球藻不同,迄今为止还没有关于盐湖盾藻蛋白质 N-糖基化途径的数据报道。在这里,我们首次通过 MALDI-TOF 质谱法研究了这种绿色微藻中的蛋白质 N-糖基化。这些分析表明,D. salina 的蛋白质通过 Man5GlcNAc2 寡甘露糖苷进行 N-糖基化。利用基因组挖掘方法,我们确定了参与盐湖虾 N-糖基化途径的蛋白质编码基因。我们还研究了假定序列与 C. reinhardtii、P. tricornutum 和人类同源物的遗传相似性和系统发育关系。这些数据表明,在 D. salina 中,核苷酸糖的生物合成和 N-聚糖的生物合成主要与 C. reinhardtii 的 GnT I 独立途径相似,该途径可产生一种非经典的低聚甘露糖 Man5GlcNAc2 的合成。虽然在D. salina基因组中发现了一种α(1,3)-岩藻糖基转移酶,但细胞膜GDP-岩藻糖生物合成的障碍阻止了N-聚糖的高尔基岩藻糖基化。总之,这些数据表明,D. salina 的蛋白质均以非典型的 Man5GlcNAc2 进行 N-糖基化。
Exploring protein N-glycosylation in the green microalga Dunaliella salina
N-glycosylation is a major post-translational modification of proteins that has a crucial influence on cell targeting, activity, and half-life. This process starts in the endoplasmic reticulum where an oligosaccharide precursor is added to the newly synthesized protein and continues in the Golgi apparatus where the N-linked carbohydrate sequences are processed. Importantly, the most approved recombinant pharmaceutical proteins (so-called biologics) are glycoproteins mainly currently produced in mammalian cells which is a lengthy, costly, and complex process. Today, several microalgae such as the diatom Phaeodactylum tricornutum, and the green microalgae Chlamydomonas reinhardtii, Chlorella vulgaris, and Dunaliella salina are considered as efficient and eco-friendly alternative platforms for the production of biologics. However, unlike for C. reinhardtii, C. vulgaris, and P. tricornutum, there is to date no data reported regarding the protein N-glycosylation pathway in D. salina. Here, we first investigated the protein N-glycosylation in this green microalga by MALDI-TOF mass spectrometry. These analyses showed that proteins from D. salina are N-glycosylated with Man5GlcNAc2 oligomannoside. Using genome mining approaches, we then identified genes encoding proteins involved in the N-glycosylation pathways in D. salina. Genetic similarities and phylogenetic relationships of the putative sequences with homologues from C. reinhardtii, P. tricornutum, and humans were investigated. These data revealed that in D. salina the biosynthesis of nucleotide sugars and N-glycan biosynthesis share mainly similarities with the GnT I-independent pathway of C. reinhardtii that gives rise to the synthesis of a non-canonical oligomannoside Man5GlcNAc2. Although an α(1,3)-fucosyltransferase is identified in the D. salina genome, impairment of the cytosolic GDP-Fuc biosynthesis prevents the Golgi fucosylation of N-glycans. Taken together, these data demonstrated that proteins from D. salina are homogeneously N-glycosylated with a non-canonical Man5GlcNAc2.
期刊介绍:
Algal Research is an international phycology journal covering all areas of emerging technologies in algae biology, biomass production, cultivation, harvesting, extraction, bioproducts, biorefinery, engineering, and econometrics. Algae is defined to include cyanobacteria, microalgae, and protists and symbionts of interest in biotechnology. The journal publishes original research and reviews for the following scope: algal biology, including but not exclusive to: phylogeny, biodiversity, molecular traits, metabolic regulation, and genetic engineering, algal cultivation, e.g. phototrophic systems, heterotrophic systems, and mixotrophic systems, algal harvesting and extraction systems, biotechnology to convert algal biomass and components into biofuels and bioproducts, e.g., nutraceuticals, pharmaceuticals, animal feed, plastics, etc. algal products and their economic assessment